首页> 外文期刊>Journal of orthopaedic research >Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study
【24h】

Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study

机译:透明质酸关节腔内注射对膝骨关节炎患者血清和尿液生物标志物的早期影响:一项开放性观察性前瞻性研究

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of the study was to investigate the effect of hyaluronic acid (HA) intra articular injections (IA) on osteoarthritis (OA) biomarkers in patients with knee OA. Prospective open label study. Fifty-one patients with unilateral symptomatic K-OA received IA injections of 2mL of HA on days (D) 1, 7, 14 and were followed 3 months. At D-15 patients were examined and X-rays performed, to exclude patients with bilateral K-OA, or those with more than three symptomatic OA joints. From 15 days (D-15) before the first injection to D90 concomitant therapies were unchanged. Walking pain (WP) on VAS was obtained at each visit. Urine (U) and serum (S) samples were obtained at D-15, D1, D30, and D90. S-C2C, S-Cartilage oligomeric matrix protein, S-HA, S-CS 846 epitope, S-type II collagen propeptide, and U-type II collagen C telopeptide (U-CTX II/creatinin) were assayed. Predictive factors of response were analyzed using logistic regression. Correlations between variables were obtained using Spearman test. Forty-five patients were analyzed. Between D-15 and D1 there was no difference for any biomarkers At D1, WP (SD) was correlated with U-CTX II/creat (p = 0.006). Between D1 and D90: U-CTX II/creat decreased significantly. After adjustment for confounding variables there was a significant correlation between clinical response and U-CTX II/creat variation. U-CTX II and S-HA at baseline were independently predictive of clinical response. This study showed that 90 days after HA IA injections, U-CTX II levels significantly decrease compared to baseline, suggesting a slowdown of type II collagen degradation.
机译:该研究的目的是研究透明质酸(HA)关节内注射(IA)对膝OA患者的骨关节炎(OA)生物标志物的影响。前瞻性开放标签研究。 51例单侧症状性K-OA患者在第(D)1、7、14天接受IA注射2mL HA,并随访3个月。在D-15时,检查患者并进行X线检查,以排除双侧K-OA或具有三个以上症状性OA关节的患者。从第一次注射前的15天(D-15)到D90的伴随疗法没有改变。每次就诊都获得了VAS的步行疼痛(WP)。在D-15,D1,D30和D90获得尿液(U)和血清(S)样品。测定了S-C2C,S-软骨寡聚基质蛋白,S-HA,S-CS 846表位,S型II型胶原蛋白原肽和U型II型胶原蛋白C端肽(U-CTX II /肌酐)。使用logistic回归分析了反应的预测因素。使用Spearman检验获得变量之间的相关性。分析了四十五名患者。在D-15和D1之间,任何生物标记均无差异。在D1,WP(SD)与U-CTX II / creat相关(p = 0.006)。在D1和D90之间:U-CTX II / creat显着下降。调整混杂变量后,临床反应与U-CTX II /创造变异之间存在显着相关性。基线时的U-CTX II和S-HA可独立预测临床反应。这项研究表明,注射HA IA后90天,与基线相比,U-CTX II水平显着降低,表明II型胶原蛋白降解减慢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号